65 results
PRE 14C
ncgntmqd ndqx8ish8
16 Dec 22
Preliminary information
4:31pm
8-K
EX-10.1
twlv46 6cgc
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.2
5s4x449jlla 88t
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
5mg2f 2wts75gx
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
D
h1vcmml el42m
31 Aug 22
$5M in debt
2:58pm
8-K
EX-10.1
gqw2hh8k f98
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm